Technology Transfer

From Process Knowledge to Reproducible GMP API Manufacturing

A successful API technology transfer requires more than transferring a process description and batch record. Process knowledge, analytical methods, control strategies, safety information and regulatory requirements must translate to the equipment, systems and operating conditions of the receiving site. Gaps that appear minor on paper can become significant when a process moves into a different manufacturing environment or increases in scale.

At Cambrex, API technology transfer begins with a detailed technical assessment and continues through manufacturing readiness, analytical transfer, cGMP execution and, where required, process performance qualification (PPQ). Cross-functional teams evaluate what is already established, identify what needs to be confirmed or addressed and define the work required to execute the process reproducibly at the receiving site.

Across our API manufacturing network, we support processes moving from API process development into cGMP manufacturing as well as established processes transferred from client facilities or other CDMOs, including second-source and commercial manufacturing programs.

A Structured Approach to API Technology Transfer

An inbound transfer starts with a detailed review of the available technical package. Depending on the program, this may include the process description, executed batch records, analytical methods, specifications, impurity history, raw material controls, safety information, equipment requirements and existing regulatory commitments.

Process chemistry, analytical, manufacturing, quality, EHS, engineering and project management evaluate this information against our manufacturing equipment and site systems. The objective is to distinguish what is well defined from what is assumed and determine what must be confirmed before cGMP manufacturing.

From this assessment, the transfer plan may include:

• Process and equipment fit assessment
• Process safety review
• Laboratory development work where required
• Analytical method familiarization, transfer or other phase-appropriate activities
• Raw material and intermediate control checks
• Laboratory demonstration batches where appropriate
• Batch record preparation
• Additional studies or controls identified through the risk assessment
• Preparation for cGMP manufacturing and, where required, PPQ

The scope depends on process maturity, available development and manufacturing history and the risks identified during transfer. This allows technical work to focus on the requirements of the individual process rather than applying the same transfer scope to every program.

Identifying and Managing Technology Transfer Risk

A formal gap and risk assessment evaluates the process before release for cGMP use. The review considers chemistry, impurity control strategy, process parameters, equipment fit, raw material controls, analytical methods, hold times, cleaning considerations, EHS risks and regulatory documentation requirements.

Particular attention is given to development assumptions and process conditions that may not translate directly to the receiving manufacturing environment. Mixing, heat transfer, filtration, drying and phase cuts can behave differently as equipment or scale changes.

Identified gaps are documented with risk rankings, recommended studies or controls, responsible owners and target dates. The resulting assessment provides a working transfer checklist for our teams and the client, creating a defined framework for addressing identified risks before cGMP execution.

Translating an API Process to Manufacturing Scale

A process that performs well in development does not necessarily translate unchanged to a different equipment train or manufacturing scale. Practical considerations such as equipment fit, endpoint criteria, impurity purge, hold times, raw material variability and sampling points are evaluated alongside operations that may depend heavily on operator judgment.

Changes in scale or equipment can also expose issues involving heat removal, gas evolution, mixing, filtration rate, cake washing, drying time and phase separation. Where additional understanding is needed, targeted laboratory work, demonstration batches or other transfer activities can be used to address identified risks before cGMP manufacturing.

When more extensive process work is required, our API process development and scale-up capabilities can provide a natural extension of the transfer program.

Analytical Method Transfer and Laboratory Readiness

Manufacturing transfer depends on analytical methods that can be reliably executed within the receiving laboratory. Methods developed outside Cambrex are reviewed to confirm that the written procedure is complete and executable as written.

The review considers sample preparation, calculations, reference standards, system suitability, chromatographic conditions, impurity coverage and instrument requirements. Our analysts then perform method familiarization or formal transfer work using our equipment, columns, reagents and data systems. Depending on program stage, this may include comparative testing and assessment of precision, accuracy, linearity, specificity, robustness, solution stability and forced or stressed samples where appropriate.

If a transferred method does not perform as expected, the issue is documented and investigated with the client to determine the root cause. The method can then be revised or remediated before use for cGMP release or stability testing.

Broader analytical development capabilities can support additional work when a method requires development beyond the scope of transfer.

Technology Transfer for Second-Source and Commercial API Manufacturing

Second-source transfers have a different objective: establishing the process within our manufacturing environment while remaining as close as practical to the established process and maintaining comparability with the existing source.

The assessment considers the current process, batch history, impurity profile, specifications, raw materials, analytical methods, equipment differences and regulatory filing strategy. Differences are evaluated to determine which are low risk and which require laboratory work, engineering batches, additional analytical comparison, impurity tracking or process-control updates.

The objective is not to redesign an established process without a technical need. Instead, we work to demonstrate that our equipment and systems can manufacture material comparable to the existing source while supporting applicable client change-control or regulatory requirements.

This approach supports companies establishing Cambrex as an additional manufacturing source as well as programs transitioning into longer-term commercial API manufacturing.

Preparing for cGMP Manufacturing and PPQ

Once identified gaps have been addressed and required transfer activities are complete, the process can move into cGMP manufacturing and, where required, PPQ.

At this stage, technical risks identified during transfer have been evaluated, required analytical work has been completed and the information needed for execution has been incorporated into the appropriate manufacturing documentation. Together, these activities establish the technical foundation for reproducible execution of the transferred process within the receiving manufacturing environment.

API Technology Transfer Across Our Manufacturing Network

Technology transfer connects established process knowledge with execution in a new manufacturing environment. Across our API manufacturing sites, we support processes moving from development into cGMP manufacturing, transfers from client facilities or other CDMOs and second-source manufacturing programs.

The approach remains grounded in the requirements of the receiving site. Rather than simply reproducing a transferred set of instructions, we evaluate how the process translates to the specific equipment, systems and operating conditions where manufacturing will occur.

That means establishing the process understanding, controls, analytical methods and manufacturing documentation needed to execute the process safely and reproducibly while maintaining the technical intent of the transferred process.